Published in Br J Cancer Suppl on June 01, 1991
Abnormalities in structure and expression of the human retinoblastoma gene in SCLC. Science (1988) 4.26
Loss of heterozygosity of chromosome 3p markers in small-cell lung cancer. Nature (1987) 2.59
Expression of epidermal growth factor receptors on human cervical, ovarian, and vulval carcinomas. Cancer Res (1986) 2.38
Establishment of continuous, clonable cultures of small-cell carcinoma of lung which have amine precursor uptake and decarboxylation cell properties. Cancer Res (1980) 2.10
Selective growth in serum-free hormone-supplemented medium of tumor cells obtained by biopsy from patients with small cell carcinoma of the lung. Proc Natl Acad Sci U S A (1981) 1.83
Monoclonal antibody JSB-1 detects a highly conserved epitope on the P-glycoprotein associated with multi-drug-resistance. Int J Cancer (1988) 1.78
Growth of human tumour cell colonies from biopsies using two soft-agar techniques. Br J Cancer (1978) 1.46
Levels of creatine kinase and its BB isoenzyme in lung cancer specimens and cultures. Cancer Res (1981) 1.30
Characterization and properties of nine human ovarian adenocarcinoma cell lines. Cancer Res (1988) 2.40
Investigation of endometrial abnormalities in asymptomatic women treated with tamoxifen and an evaluation of the role of endometrial screening. J Clin Oncol (1999) 2.13
Children, stress, and hospitalization: a field experiment. J Health Soc Behav (1968) 2.11
Light chain isotype-associated suppression of normal plasma cell numbers in patients with multiple myeloma: Medical Research Council's Working Party for Leukaemia in Adults and the Oxford Lymphoma Group. Int J Cancer (1979) 1.75
Quinidine as a resistance modulator of epirubicin in advanced breast cancer: mature results of a placebo-controlled randomized trial. J Clin Oncol (1994) 1.58
Chemotherapy prolongs survival in inoperable pancreatic carcinoma. Br J Surg (1994) 1.57
Small-cell lung cancer after retinoblastoma. Lancet (1989) 1.48
Chromosomal aberration and sister-chromatid exchange frequencies in peripheral blood lymphocytes of a large human population sample. II. Extension of age range. Mutat Res (1989) 1.46
The natural history of low grade non-Hodgkin's lymphoma and the impact of a no initial treatment policy on survival. Q J Med (1991) 1.45
p53 mutation is a common genetic event in ovarian carcinoma. Cancer Res (1993) 1.45
Immunoperoxidase staining of surface and intracellular immunoglobulin in human neoplastic lymphoid cells. J Clin Pathol (1980) 1.45
Antigens on human plasma cells identified by monoclonal antibodies. J Immunol (1983) 1.41
Normal G2 chromosomal radiosensitivity and cell survival in the cancer family syndrome. Cancer Res (1988) 1.37
Tamoxifen as primary treatment of breast cancer in elderly or frail patients: a practical management. Br Med J (Clin Res Ed) (1985) 1.29
Aromatase inhibitors and arthralgia. J Clin Oncol (2001) 1.27
The impact of chemotherapy on small cell carcinoma of the bronchus. Q J Med (1986) 1.26
Information giving in oncology: a preliminary study of tape-recorder use. Br J Clin Psychol (1992) 1.22
Allele losses on chromosome 17 in human epithelial ovarian carcinoma. Oncogene (1990) 1.19
Primary systemic therapy for operable breast cancer. Br J Cancer (1991) 1.19
Incidence of Endemic Entomopathogenic Nematodes Following Application of Steinernema riobrave for Control of Diaprepes abbreviatus. J Nematol (2003) 1.14
Phase II trial of vindesine and VP16-213 in the palliation of poor-prognosis patients and elderly patients with small cell lung cancer. Cancer Chemother Pharmacol (1984) 1.07
Primary systemic therapy for operable breast cancer--10-year survival data after chemotherapy and hormone therapy. Br J Cancer (1997) 1.07
Estimating Sample Size and Persistence of Entomogenous Nematodes in Sandy Soils and Their Efficacy Against the Larvae of Diaprepes abbreviatus in Florida. J Nematol (1996) 1.05
Dexamethasone and high dose metoclopramide: efficacy in controlling cisplatin induced nausea and vomiting. Br Med J (Clin Res Ed) (1984) 1.03
Overexpression of the p53 protein and allele loss at 17p13 in ovarian carcinoma. Br J Cancer (1992) 1.03
Does dexamethasone enhance control of acute cisplatin induced emesis by ondansetron? BMJ (1991) 1.02
Paradoxical embolism. A review of cases diagnosed during life. Eur Heart J (1982) 1.01
A 10-year experience of tamoxifen as primary treatment of breast cancer in 100 elderly and frail patients. Eur J Surg Oncol (1991) 1.00
Competition Between Entomopathogenic and Free-Living Bactivorous Nematodes in Larvae of the Weevil Diaprepes abbreviatus. J Nematol (2003) 1.00
Definition and refinement of a region of loss of heterozygosity at 11q23.3-q24.3 in epithelial ovarian cancer associated with poor prognosis. Cancer Res (1996) 0.99
Effect of sodium butyrate and other differentiation inducers on poorly differentiated human ovarian adenocarcinoma cell lines. Cancer Res (1988) 0.99
Root growth and carbohydrate responses in bearing citrus trees following partial canopy removal. Tree Physiol (1992) 0.98
Miltefosine as a topical treatment for cutaneous metastases in breast carcinoma. Cancer Chemother Pharmacol (1999) 0.98
Bionomics of a Phoretic Association Between Paenibacillus sp. and the Entomopathogenic Nematode Steinernema diaprepesi. J Nematol (2005) 0.97
Prospective randomized study of surgical morbidity following primary systemic therapy for breast cancer. Br J Surg (1995) 0.97
Chromosomal aberration and sister-chromatid exchange frequencies in peripheral blood lymphocytes of a large human population sample. Mutat Res (1988) 0.96
Preliminary results of the use of urinary excretion of pyridinium crosslinks for monitoring metastatic bone disease. Br J Cancer (1992) 0.96
Immunocytological detection of residual marrow disease at clinical remission predicts metastatic relapse in small cell lung cancer. Cancer Res (1990) 0.94
Letrozole as primary medical therapy for locally advanced and large operable breast cancer. Breast Cancer Res Treat (2001) 0.94
Optimising antiemesis in cancer chemotherapy: efficacy of continuous versus intermittent infusion of high dose metoclopramide in emesis induced by cisplatin. Br Med J (Clin Res Ed) (1986) 0.94
A familial RB1 mutation detected by the HOT technique is homozygous in a second primary neoplasm. Oncogene (1991) 0.93
Effect of temperature upon relative viscosity of normal and myeloma serum. Br J Haematol (1981) 0.93
More money is needed to care for patients with cancer. BMJ (1997) 0.93
Continuous 5-fluorouracil in the treatment of breast cancer. Br J Cancer (1994) 0.92
Emesis due to cancer chemotherapy: results of a prospective, randomised, double-blind trial of varying doses of metoclopramide in the management of cis-platinum-induced vomiting. Eur J Cancer Clin Oncol (1984) 0.92
An Algorithm for Fitting Seinhorst Curves to the Relationship between Plant Growth and Preplant Nematode Densities. J Nematol (1981) 0.91
Spatial patterns of entomopathogenic nematodes in microcosms: implications for laboratory experiments. J Nematol (1996) 0.90
Prognostic factors for survival in soft tissue sarcoma. Br J Cancer (1990) 0.89
Abundance of Diaprepes abbreviatus (L.) (Coleoptera: Curculionidae) neonates falling to the soil under tree canopies in Florida citrus groves. J Econ Entomol (2003) 0.88
Prognostic factors in non-Hodgkin's lymphoma: the importance of symptomatic stage as an adjunct to the Kiel histopathological classification. Br J Cancer (1983) 0.88
Behçet's syndrome and neutropenia. Postgrad Med J (1981) 0.88
Protective effect of sodium-2-mercaptoethanesulfonate on the gastrointestinal toxicity and lethality of cis-diamminedichloroplatinum. Cancer Res (1986) 0.88
Chromosome 11 allele imbalance and clinicopathological correlates in ovarian tumours. Br J Cancer (1995) 0.88
Loss of heterozygosity at 11q22 correlates with low progesterone receptor content in epithelial ovarian cancer. Clin Cancer Res (1995) 0.87
Paraneoplastic hypercalcaemia in ovarian carcinoma. Br Med J (Clin Res Ed) (1984) 0.87
Prognosis in small cell carcinoma of the lung--relationship to human milk fat globule 2 (HMFG2) antigen and other small cell associated antigens. Br J Cancer (1987) 0.87
A Medical Research Council phase II trial of alternating chemotherapy and radiotherapy in small-cell lung cancer. The Medical Research Council Lung Cancer Working Party. Br J Cancer (1991) 0.86
Specialist surgeons and survival in breast cancer. A multidisciplinary approach is needed. BMJ (1996) 0.86
Serum placental-like alkaline phosphatase (PLAP): a novel combined enzyme linked immunoassay for monitoring ovarian cancer. J Clin Pathol (1989) 0.86
Augmenting Entomopathogenic Nematodes in Soil from a Florida CitrusOrchard: Non-Target Effects of a Trophic Cascade. J Nematol (2007) 0.86
Allele loss on chromosome 11p is associated with poor survival in ovarian cancer. Dis Markers (1993) 0.86
Recording of outpatient consultations. Lancet (1992) 0.86
Spatial Patterns of Belonolaimus spp. Among and Within Citrus Orchards on Florida's Central Ridge. J Nematol (1996) 0.85
Side effects expected and experienced by women receiving chemotherapy for breast cancer. BMJ (1991) 0.85
Dystonic reactions due to metoclopramide. Lancet (1984) 0.84
Leaching Soluble Salts Increases Population Densities of Tylenchulus semipenetrans. J Nematol (1992) 0.84
The prognostic value of early CA125 serum assay in epithelial ovarian carcinoma. Br J Cancer (1993) 0.84
Multiple myeloma: radiology or bone scanning? Clin Radiol (1981) 0.84
Clinical applications of immunocytochemistry in the monitoring of the bone marrow in small cell lung cancer (SCLC). Int J Cancer Suppl (1988) 0.84
Dexamethasone antiemesis and side-effects. Lancet (1986) 0.83
Relationship between serum viscosity and intravascular IgA polymer concentration in IgA myeloma. Clin Exp Immunol (1981) 0.83
Ischaemic heart disease mortality study among workers with occupational exposure to ammonium perfluorooctanoate. Occup Environ Med (2009) 0.83
Miltefosine in recurrent cutaneous breast cancer. Lancet (1997) 0.83
The heterogeneity of human cancers and its influence on metastases and therapy. Eur J Cancer Clin Oncol (1985) 0.83
Chromosomal aberrations and sister-chromatid exchanges in lymphocytes from coke oven workers. Mutat Res (1988) 0.83
Paradoxical embolism associated with patent foramen ovale. Postgrad Med J (1981) 0.83
Anti-emetic efficacy of dexamethasone in combination for out-patients receiving cytotoxic chemotherapy. Cancer Chemother Pharmacol (1986) 0.83
Nematode Community Composition under Various Irrigation Schemes in a Citrus Soil Ecosystem. J Nematol (1998) 0.82
Analyzing spatial patterns linked to the ecology of herbivores and their natural enemies in the soil. Front Plant Sci (2013) 0.82
Weekly doxorubicin and continuous infusional 5-fluorouracil for advanced breast cancer. Br J Cancer (1996) 0.81
Antitumour activity and schedule dependency of 8-chloroadenosine-3',5'-monophosphate (8-ClcAMP) against human tumour xenografts. Eur J Cancer (1998) 0.81
Mathematical modelling of tumour response in primary breast cancer. Br J Cancer (1996) 0.81
Distribution of plasma cells in normal rectal mucosa. J Clin Pathol (1982) 0.81
Prognosis at presentation of small cell carcinoma of the lung. Eur J Cancer (1990) 0.81
Sensitive determination of 8-chloroadenosine 3',5'-monophosphate and 8-chloroadenosine in plasma by high-performance liquid chromatography. J Chromatogr B Biomed Appl (1994) 0.81
Lessons from the use of aromatase inhibitors in the neoadjuvant setting. Endocr Relat Cancer (1999) 0.81
High-dose chemotherapy for metastatic breast cancer. Lancet (1994) 0.80
A review of the epidemiology of 1,3-butadiene and chloroprene. Chem Biol Interact (2001) 0.80
Phase I study of TCNU, a novel nitrosourea. Eur J Cancer Clin Oncol (1987) 0.80
Infection of Citrus Roots by Tylenchulus semipenetrans Reduces Root Infection by Phytophthora nicotianae. J Nematol (2002) 0.80
Locally advanced breast cancer: report of phase II study and subsequent phase III trial. Br J Cancer (1992) 0.79
Low grade stage I and II non-Hodgkin's lymphoma: results of treatment and relapse pattern following therapy. Clin Radiol (1988) 0.79
Infusional 5-fluorouracil in breast cancer. Cancer Treat Rev (1994) 0.79
Potentiation of cisplatin by alpha-interferon in advanced non-small cell lung cancer (NSCLC): a phase II study. Ann Oncol (1990) 0.79
Docetaxel in the community setting: an analysis of 377 breast cancer patients treated with docetaxel (Taxotere) in the UK. UK Study Group. Ann Oncol (1999) 0.79
High-dose ifosfamide in combination with etoposide and epirubicin (IVE) in the treatment of relapsed/refractory Hodgkin's disease and non-Hodgkin's lymphoma: a report on toxicity and efficacy. Eur J Haematol Suppl (2001) 0.79
ABC of breast disease. Locally advanced breast cancer. BMJ (1994) 0.79
High-dose gallium imaging in lymphoma. Am J Med (1983) 0.78
A critical analysis of prognostic factors for survival in intermediate and high grade non-Hodgkin's lymphoma. Scotland and Newcastle Lymphoma Group Therapy Working Party. Br J Cancer (1991) 0.78